Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function

被引:65
作者
Laechelt, S. [1 ]
Turrini, E. [1 ]
Ruehmkorf, A. [1 ]
Siegmund, W. [2 ]
Cascorbi, I. [1 ]
Haenisch, S. [1 ]
机构
[1] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, D-24105 Kiel, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Dept Pharmacol, Div Clin Pharmacol, Greifswald, Germany
关键词
MRP2; haplotype; polymorphism; ABC transporters; pharmacogenetics; drug distribution; TRANSPLANT RECIPIENTS; PROTEIN EXPRESSION; MESSENGER-RNA; POLYMORPHISMS; PHARMACOKINETICS; SUSCEPTIBILITY; ASSOCIATION; METHOTREXATE; MRP2/ABCC2; VARIANTS;
D O I
10.1038/tpj.2010.20
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
ABCC2 (MRP2) is an important export pump, expressed at tissue barriers. The genetic variants -24C>T, 1249G>A and 3972C>T are leading to inter-individual differences of bioavailability of various endogenous and exogenous compounds. Considering ABCC2 haplotypes, we investigated DNA-protein binding properties, mRNA secondary structure, mRNA stability, protein expression and transport activity in various cell lines and analyzed the bioavailability of talinolol in 24 healthy Caucasian volunteers; -24C>T had no clear influence on DNA-protein binding and the mRNA stability did not differ significantly. In transfected HEK293T/17 cells, haplotypes H9 (CGT), H10 (TGC) and H12 (TGT) had significantly lower protein expression, whereas H2 (CAC) exhibited significantly increased protein expression compared to the wild type (H1, CGC): 32.7 +/- 8.8, 73.1 +/- 6.3; 44.0 +/- 15.5 and 115.2 +/- 8.2%, respectively. This corresponded with efflux rates of the fluorescent dye glutathione-methylfluorescein in vitro and by trend with talinolol bioavailability in vivo. In conclusion our results show a haplotype-dependent influence on transport capacity of ABCC2, which seems to be mainly based on posttranscriptional modification of protein expression rather than transport rates. The Pharmacogenomics Journal (2011) 11, 25-34; doi: 10.1038/tpj.2010.20; published online 30 March 2010
引用
收藏
页码:25 / 34
页数:10
相关论文
共 22 条
[1]   Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs [J].
Cascorbi, Ingolf .
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (02) :457-473
[2]   MRP2 haplotypes confer differential susceptibility to toxic liver injury [J].
Choi, Ji Ha ;
Ahn, Byung Min ;
Yi, Jihyun ;
Lee, Ji Hyun ;
Lee, Jeong Ho ;
Nam, Soon Woo ;
Chon, Chae Yoon ;
Han, Kwang-Hyub ;
Ahn, Sang Hoon ;
Jang, In-Jin ;
Cho, Joo-Youn ;
Suh, Yousin ;
Cho, Mi-Ook ;
Lee, Jong-Eun ;
Kim, Kyung Hwan ;
Lee, Min Goo .
PHARMACOGENETICS AND GENOMICS, 2007, 17 (06) :403-415
[3]   Genetic susceptibility to diclofenac-induced hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 genotypes [J].
Daly, Ann K. ;
Aithal, Guruprasad P. ;
Leathart, Julian B. S. ;
Swainsbury, Richard A. ;
Dang, Tarana Singh ;
Day, Christopher P. .
GASTROENTEROLOGY, 2007, 132 (01) :272-281
[4]   Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview [J].
Day, DA ;
Tuite, MF .
JOURNAL OF ENDOCRINOLOGY, 1998, 157 (03) :361-371
[5]   Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex [J].
Haenisch S. ;
Zimmermann U. ;
Dazert E. ;
Wruck C.J. ;
Dazert P. ;
Siegmund S. ;
Kroemer H.K. ;
Warzok R.W. ;
Cascorbi I. .
The Pharmacogenomics Journal, 2007, 7 (1) :56-65
[6]   Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol [J].
Haenisch, Sierk ;
May, Karen ;
Wegner, Danilo ;
Caliebe, Amke ;
Cascorbi, Ingolf ;
Siegmund, Werner .
PHARMACOGENETICS AND GENOMICS, 2008, 18 (04) :357-365
[7]   Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer [J].
Han, Ji-Youn ;
Lim, Hyeong-Seok ;
Yoo, Yeon-Kyeong ;
Shin, Eun Soon ;
Park, Yong Hoon ;
Lee, Sung Young ;
Lee, Jong-Eun ;
Lee, Dea Ho ;
Kim, Heung Tae ;
Lee, Jin Soo .
CANCER, 2007, 110 (01) :138-147
[8]   Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2 [J].
Hirouchi, M ;
Suzuki, H ;
Itoda, M ;
Ozawa, S ;
Sawada, J ;
Ieiri, I ;
Ohtsubo, K ;
Sugiyama, Y .
PHARMACEUTICAL RESEARCH, 2004, 21 (05) :742-748
[9]   Association of the c.3972C>T Variant of the Multidrug Resistance-Associated Protein 2 Gene (MRP2/ABCC2) with Susceptibility to Bile Duct Cancer [J].
Hoeblinger, A. ;
Gruenhage, F. ;
Sauerbruch, T. ;
Lammert, F. .
DIGESTION, 2009, 80 (01) :36-39
[10]   Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics [J].
Innocenti, Federico ;
Kroetz, Deanna L. ;
Schuetz, Erin ;
Dolan, M. Eileen ;
Ramirez, Jacqueline ;
Relling, Mary ;
Chen, Peixian ;
Das, Soma ;
Rosner, Gary L. ;
Ratain, Mark J. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) :2604-2614